Endothelix is dedicated to bringing endothelial function monitoring to physicians' offices and patients homes much like automated blood pressure monitoring is today. In fact, Endothelix's VENDYS-ll svstem is the onlv FDA-cleared device that combines both B and EF monitoring in an easy-to-use, operator-independent system.
HeartLung.Al focuses on early detection of heart disease and lung cancer using deep learning, noninvasive imaging, mobiles apps and smartphones. Heart attack and lung cancer are the number one and number two killers in the US Over 50 million Americans can benefit from such Al-powered early detection technologies. More will be disclosed later.
Cardio Nexus Corporation is dedicated to reducing cardiovascular disease through early detection and primary prevention.
CardioNexus' flagship product, the CardioHealth® Station, is a new multi-modality initiative to advance cardiovascular health assessment for the prevention of heart attack and stroke.
Dr. Me! is focused on Al-powered self-administered consumer-centric personalized healthcare products. The company's goal is o allow anyone to monitor determinants of their health using low-cost self-administered home-based diagnostic modalities, self-administer certain therapies, and receive
Al-powered personalized medical consultation 24/7.